A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis
Clinical trial NCT02584777 · WITHDRAWN
Trial details
- NCT number
- NCT02584777
- Sponsor
- Baxalta now part of Shire
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2017-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.